Role of the Wnt/β-catenin signaling pathway in inducing apoptosis and Renal fibrosis in 5/6-nephrectomized rats

Molecular Medicine Reports

Volumn 15, Issue 6, 2017, Pages 3575-3582

  Lin, Xin ^a   Zha, Yan ^a   Zeng, Xiang Zhen ^b   Dong, Rong ^a   Wang, Qing Hua ^b   Wang, Dong Tao ^c,d  

^a GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Loudi Central Hospital   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Apoptosis; Chronic kidney disease; Fibrosis; Renal; Wnt catenin signaling

Indexed keywords

BETA CATENIN; CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FIBRONECTIN; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; WNT PROTEIN; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IN VITRO STUDY; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; NEPHRECTOMY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUNEL ASSAY; WNT SIGNALING PATHWAY; ANIMAL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; WNT SIGNALING;

ANIMALS; APOPTOSIS; BETA CATENIN; BIOMARKERS; DISEASE MODELS, ANIMAL; FIBROSIS; GENE SILENCING; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MALE; NEPHRECTOMY; RATS; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA; WNT SIGNALING PATHWAY;

EID: 85019629599     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2017.6461     Document Type: Article

References (31)

1. Kazancioǧlu R: Risk factors for chronic kidney disease: An update. Kidney Int Suppl (2011) 3:368-371, 2013.
2. Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ and Nguyen TQ: Diverse origins of the myofibroblast-implications for kidney fibrosis. Nat Rev Nephrol 11:233-244, 2015.
3. Guo Y, Xiao L, Sun L and Liu F: Wnt/beta-catenin signaling: A promising new target for fibrosis diseases. Physiol Res 61:337-346, 2012.
4. Sutariya B, Jhonsa D and Saraf M N: TGF-β: The connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol 38:39-49, 2016.
5. Wynn TA: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117:524-529, 2007.
6. Kriz W, Kaissling B and Le Hir M: Epithelial-mesenchymal transition (EMT) in kidney fibrosis: Fact or fantasy? J Clin Invest 121:468-474, 2011.
7. Eger A, Stockinger A, Park J, Langkopf E, Mikula M, Gotzmann J, Mikulits W, Beug H and Foisner R: Beta-catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23:2672-2680, 2004.
8. Sato M: Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 86:300-307, 2006.
9. Cheng JH, She H, Han Y P, Wang J, Xiong S, Asahina K and Tsukamoto H: Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol 294:G39-G49, 2008.
10. Wei J, Melichian D, Komura K, Hinchcliff M, Lam AP, Lafyatis R, Gottardi CJ, MacDougald OA and Varga J: Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma? Arthritis Rheum 63:1707-1717, 2011.
11. Zhou T, He X, Cheng R, Zhang B, Zhang RR, Chen Y, Takahashi Y, Murray AR, Lee K, Gao G and Ma JX: Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 55:255-266, 2012.
12. He W, Dai C, Li Y, Zeng G, Monga S P and Liu Y: Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20:765-776, 2009.
13. Hao S, He W, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M and Liu Y: Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22:1642-1653, 2011.
14. Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al: Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 3:735, 2012.
15. Arend RC, Londoño-Joshi AI, Samant RS, Li Y, Conner M, Hidalgo B, Alvarez RD, Landen CN, Straughn JM and Buchsbaum DJ: Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer. Gynecol Oncol 134:112-120, 2014.
16. Wang C, Zhu H, Sun Z, Xiang Z, Ge Y, Ni C, Luo Z, Qian W and Han X: Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury. Am J Physiol Cell Physiol 307:C234-C244, 2014.
17. Tanjore H, Degryse AL, Crossno PF, Xu XC, McConaha ME, Jones BR, Polosukhin VV, Bryant AJ, Cheng DS, Newcomb DC, et al: β-Catenin in the alveolar epithelium protects from lung fibrosis after intratracheal bleomycin. Am J Respir Crit Care Med 187:630-639, 2013.
18. Wang DT, Huang RH, Cheng X, Zhang ZH, Yang YJ and Lin X: Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and N F-κB signaling pathway in 5/6 nephrectomized rats. Int Immunopharmacol 26:4-12, 2015.
19. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(Delta Delta C (T)) method. Methods 25:402-408, 2001.
20. Verma UN, Surabhi RM, Schmaltieg A, Becerra C and Gaynor RB: Small interfering RNAs directed against β-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin Cancer Res 9:1291-1300, 2003.
21. Schneider CA, Rasband WS and Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671-675, 2012.
22. Tan RJ, Zhou D, Zhou L and Liu Y: Wnt/β-catenin signaling and kidney fibrosis. Kidney Int Suppl (2011) 4:84-90, 2014.
23. Zhou D, Tan RJ, Fu H and Liu Y: Wnt/β-catenin signaling in kidney injury and repair: A double-edged sword. Lab Invest 96:156-167, 2016.
24. Peng J and Dong Z: Role changes of β-catenin in kidney injury and repair. Kidney Int 82:509-511, 2012.
25. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB and Liu Y: Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20:1997-2008, 2009.
26. Von Toerne C, Schmidt C, Adams J, Kiss E, Bedke J, Porubsky S, Gretz N, Lindenmeyer MT, Cohen CD, Gröne HJ and Nelson PJ: Wnt pathway regulation in chronic renal allograft damage. Am J Transplant 9:2223-2239, 2009.
27. Xiao L, Zhou D, Tan RJ, Fu H, Zhou L, Hou FF and Liu Y: Sustained activation of Wnt/β-Catenin signaling drives AKI to CKD progression. J Am Soc Nephrol 27:1724-1740, 2016.
28. Lin CL, Cheng H, Tung CW, Huang WJ, Chang PJ, Yang JT and Wang J Y: Simvastatin reverses high glucose-induced apoptosis of mesangial cells via modulation of Wnt Signaling pathway. Am J Nephrol 28:290-297, 2008.
29. Haramis AP, Begthel H, Van Den Born M, Van Es J, Jonkheer S, Offerhaus GJ and Clevers H: De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 30:1684-1686, 2004.
30. Polakis P: The many ways of Wnt in cancer. CurrOpin Genet Dev 17:45-51, 2007.
31. Zhou L, Li Y, Zhou D, Tan RJ and Liu Y: Loss of Klotho contributes to kidney injury by derepression of Wnt/β-Catenin signaling. J Am Soc Nephrol 24:771-785, 2013.